SAN FRANCISCO, March 2, 2020 /PRNewswire/ -- The global stem cell marketsize is expected to reach USD 17.9 billion by 2027, expanding at a CAGR of 8.2%, according to a new report by Grand View Research, Inc. Recent advances in tissue engineering strategies hold the potential to draw attention to the treatment of several chronic disorders. Moreover, automation in adult and cord blood processing and storage is expected to drive market growth significantly.
Key suggestions from the report:
Adult stem cells (ASCs) segment occupied the largest share of the products in 2019 and is expected to maintain its dominance across the analysis period
Factors such as long term renewal property, low rejection rates, and minimal ethical concerns associated with the utility of ASCs are attributive towards larger market share
The regenerative medicine segment accounted for the largest share of owing to a huge pipeline for regenerative medicine products
The cell acquisition technology segment occupied a major revenue share and is anticipated to witness the fastest CAGR over the forecast period owing to a rise in the number of research projects that require the application of cell harvesting technologies
Allogenic therapy is the most commonly adopted therapy owing to its graft-versus-cancer response in cancer treatment and graft-versus-host response in organ or tissue transplant
These responses allow allogenic stem cells to kill the cancer remaining after drug therapy and to prevent organ rejection and other complications post-surgery
Presence of major companies, extensive government funding, and increasing research have contributed to the largest market share in North America
The Asia Pacific region is expected to grow at a lucrative pace owing to strong product pipelines in regenerative therapies and large patient population
Osiris Therapeutics Inc; BIOTIME, INC.; Celgene Corporation; STEMCELL Technologies Inc.; and Cynata are some of the key players operating in the stem cells market.
The key players are undertaking strategic initiatives to maintain their market share. They are keen to seek investment from other bodies and also collaborate with other pharmaceutical giants. This is set to enhance market growth over the forecast period.
The development of banking facilities and resultant enhancement of stem cell production, storage, and characterization are also expected to enhance the volumetric capabilities of this therapy, globally. This would lead to revenue generation in the global market.
Regenerative medicine and cellular therapies are considered to transform the healthcare industry in a few years. Therefore, key players are focused on developing advanced therapeutics for the treatment of Alzheimer's disease, Parkinson's disease, degenerative eye disorders, cancer, and stroke. Most of these therapies are under clinical trials and are expected to be launched soon.
Furthermore, the presence of a strong, diverse clinical pipeline is expected to accelerate revenue generation in the global market. Easy access to data through genomic, proteomic, and EHR databases has encouraged companies to investigate various therapies to aid in the treatment of previously untreatable conditions.
Grand View Research has segmented the global stem cells market on the basis of product, application, technology, therapy, and region:
Stem Cells Product Outlook (Revenue, USD Million, 2016 - 2027)
Adult Stem Cells (ASCs)
Umbilical Cord ASCs
Dedifferentiated fat (DFAT) Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Very Small Embryonic Like Stem Cells
Stem Cells Application Outlook (Revenue, USD Million, 2016 - 2027)
Cardiovascular and Myocardial Infraction
Drug Discovery and Development
Stem Cells Technology Outlook (Revenue, USD Million, 2016 - 2027)
Bone Marrow Harvest
Umbilical Blood Cord
Expansion and Sub-Culture
Stem Cells Therapy Outlook (Revenue, USD Million, 2016 - 2027)
Stem Cells Regional Outlook (Revenue, USD Billion, 2016 - 2027)
Tissue Sectioning Market – Global tissue sectioning market size was worth USD 518.58 million in 2019 and is projected to register a CAGR of 6.56% over the forecast period.
Protein Stability Analysis Market – Global protein stability analysis market size was valued at USD 985.8 million in 2019 and is expected to register a CAGR of 10.8% over the forecast period.
Single Cell Analysis Market – Global single cell analysis market size was estimated at 2.29 billion in 2019 and is projected to expand at a CAGR of 16.9% during the forecast period.
Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.